Cargando…

Recurrent Somatic Copy Number Alterations and Their Association with Oncogene Expression Levels in High-Grade Ovarian Serous Carcinoma

Somatic copy number alterations (SCNAs) are frequently observed in high-grade ovarian serous carcinoma (HGOSC). However, their impact on gene expression levels has not been systematically assessed. In this study, we explored the relationship between recurrent SCNA and gene expression using The Cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esplen, Hillary P., Yang, Richard K., Kalia, Awdhesh, Tang, Zhenya, Tang, Guilin, Medeiros, L. Jeffrey, Toruner, Gokce A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672014/ https://www.ncbi.nlm.nih.gov/pubmed/38004332 http://dx.doi.org/10.3390/life13112192

Ejemplares similares

KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma
por: Saglam, Ozlen, et al.
Publicado: (2020)

MET Expression Level in Lung Adenocarcinoma Loosely Correlates with MET Copy Number Gain/Amplification and Is a Poor Predictor of Patient Outcome
por: Yin, Wei, et al.
Publicado: (2022)

The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
por: Smith, Philip, et al.
Publicado: (2023)

Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
por: Martins, Filipe Correia, et al.
Publicado: (2022)

Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
por: Smith, Philip, et al.
Publicado: (2023)

Is hyperdiploidy a favorable cytogenetics in adults with B‐lymphoblastic leukemia?
por: Chen, Zhining, et al.
Publicado: (2019)

Association of Copy Number Variation Signature and Survival in Patients With Serous Ovarian Cancer
por: Graf, Ryon P., et al.
Publicado: (2021)

Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression
por: Roszik, Jason, et al.
Publicado: (2016)

Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer
por: Adamson, A.W., et al.
Publicado: (2023)

Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer
por: Adamson, A. W., et al.
Publicado: (2023)

Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas.
por: Tapper, J., et al.
Publicado: (1997)

Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma
por: Marchocki, Zibi, et al.
Publicado: (2022)

Oncogenes in high grade serous adenocarcinoma of the ovary
por: Manasa, Pacharla, et al.
Publicado: (2020)

Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study
por: Dugo, Matteo, et al.
Publicado: (2019)

Predictive Modeling Using a Somatic Mutational Profile in Ovarian High Grade Serous Carcinoma
por: Sohn, Insuk, et al.
Publicado: (2013)

Pathogenic Heteroplasmic Somatic Mitochondrial DNA Mutation Confers Platinum-Resistance and Recurrence of High-Grade Serous Ovarian Cancer
por: Ni, Jing, et al.
Publicado: (2020)

Somatic Copy Number Alterations Associated with Japanese or Endometriosis in Ovarian Clear Cell Adenocarcinoma
por: Okamoto, Aikou, et al.
Publicado: (2015)

CNValidator: validating somatic copy-number inference
por: Smith, Lucian P, et al.
Publicado: (2019)

BRCA1/2 variants and copy number alterations status in non familial triple negative breast cancer and high grade serous ovarian cancer
por: El Ansari, Fatima Zahra, et al.
Publicado: (2022)

Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma
por: Kinnaman, Michael D., et al.
Publicado: (2023)

Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma
por: Kinnaman, Michael D., et al.
Publicado: (2023)

Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer
por: Eoh, Kyung Jin, et al.
Publicado: (2020)

Differential Sensitivity of Germline and Somatic BRCA Variants to PARP Inhibitor in High-Grade Serous Ovarian Cancer
por: Vendrell, Julie A., et al.
Publicado: (2023)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Identifying Key Somatic Copy Number Alterations Driving Dysregulation of Cancer Hallmarks in Lower-Grade Glioma
por: Zhou, Yao, et al.
Publicado: (2021)

Pan-cancer patterns of somatic copy-number alteration
por: Zack, Travis I., et al.
Publicado: (2013)

Robustness of the Autophagy Pathway to Somatic Copy Number Losses
por: Polo, Pierfrancesco, et al.
Publicado: (2022)

Clinical Impact of Somatic Variants in Homologous Recombination Repair-Related Genes in Ovarian High-Grade Serous Carcinoma
por: Choi, Min Chul, et al.
Publicado: (2020)

Predicting Stage-Specific Recurrent Aberrations From Somatic Copy Number Dataset
por: Aouiche, Chaima, et al.
Publicado: (2020)

Copy number of latent viruses, oncogenicity, and the microcompetition model
por: Polansky, Hanan, et al.
Publicado: (2018)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer
por: De Marco, Carmela, et al.
Publicado: (2021)

Differential Expression Profiles and Function Prediction of Transfer RNA-Derived Fragments in High-Grade Serous Ovarian Cancer
por: Chen, Buze, et al.
Publicado: (2021)

Data on MECOM rearrangement-driven chromosomal aberrations in myeloid malignancies
por: Tang, Zhenya, et al.
Publicado: (2019)

DNA cytosine deamination is associated with recurrent Somatic Copy Number Alterations in stomach adenocarcinoma
por: Shi, Yilin, et al.
Publicado: (2023)

FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer
por: Fan, Qipeng, et al.
Publicado: (2015)

The landscape of somatic copy-number alteration across human cancers
por: Beroukhim, Rameen, et al.
Publicado: (2010)

Controlled Somatic and Germline Copy Number Variation in the Mouse Model
por: Hérault, Yann, et al.
Publicado: (2010)

SCNVSim: somatic copy number variation and structure variation simulator
por: Qin, Maochun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sljsvjf83arjtj4oj3nfu3quib